Genmedica Therapeutics is a development-stage biotechnology company focused on type 2 diabetes. They believe that although there are a number of oral drug classes that effectively lower glycemia, in fact, there are currently no good diabetes drugs. Namely, drugs that lower glycemia and are disease modifiers: slowing or halting the progression of the disease. Genmedica Therapeutics was founded in 2004 and is based in Barcelona, Spain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.